Suppr超能文献

每日食用一种抗炎膳食补充剂混合物可减轻疼痛并改善血管健康。

Pain reduction and improved vascular health associated with daily consumption of an anti-inflammatory dietary supplement blend.

作者信息

Hamilton Debby E, Jensen Gitte S

机构信息

Researched Nutritionals, Los Olivos, CA, USA.

NIS Labs, Klamath Falls 1437, OR, USA.

出版信息

J Pain Res. 2019 May 15;12:1497-1508. doi: 10.2147/JPR.S189064. eCollection 2019.

Abstract

The objective for this clinical pilot study was to evaluate changes to chronic pain, vascular health, and inflammatory markers when consuming a dietary supplement blend (DSB, CytoQuel), containing curcumin, resveratrol, tocotrienols, N-Acetylcysteine, and epigallocatechin gallate. An open-label study design was used where 21 study participants were evaluated at baseline and at 2 and 8 weeks after consuming DSB. Participants were randomized to consume 3 capsules once daily versus 2 capsules twice daily. Pain and activities of daily living questionnaires were used to gather subjective data on pain levels and interference with daily living. Blood pressure was measured in both arms and ankles, and the ankle-brachial index (ABI) calculated. Blood samples were used to evaluate markers associated with inflammation and cardiovascular health. Highly significant reduction of chronic pain was seen after 8 weeks (<0.01), both at rest and when physically active. Faster improvement was seen when consuming 3 capsules once daily, compared to 2 capsules twice daily. The pain reduction resulted in improved sleep quality (<0.1), and improved social functioning (<0.01), and less need for support from others (<0.05), Normalization of mildly elevated ABI at study start was seen after 2 weeks. Plasma fibrinogen and von Willebrand Factor and serum matrix metalloproteinase-9 (MMP-9) showed reduction after 2 weeks (not significant), whereas a reduction in serum interleukin-1 receptor antagonist-a (IL-1ra) was statistically significant after 2 weeks (<0.05). Correlation between pain reduction and changes to MMP-9 after 8 weeks was highly significant (<0.01), whereas correlation between pain reduction and changes to IL-1ra reached significance at 2 weeks for the group consuming 3 caps once daily (<0.04). Consuming DSB helped manage pain, increased comfort during daily activities, and improved vascular function. This was associated with selective effects on specific blood biomarkers associated with inflammation and vascular health.

摘要

这项临床试点研究的目的是评估食用一种包含姜黄素、白藜芦醇、生育三烯酚、N-乙酰半胱氨酸和表没食子儿茶素没食子酸酯的膳食补充剂混合物(DSB,CytoQuel)时,慢性疼痛、血管健康和炎症标志物的变化。采用开放标签研究设计,对21名研究参与者在基线时以及食用DSB后2周和8周进行评估。参与者被随机分为每天服用3粒胶囊组和每天服用2粒胶囊,分两次服用组。使用疼痛和日常生活问卷收集关于疼痛程度和对日常生活干扰的主观数据。测量双臂和脚踝的血压,并计算踝臂指数(ABI)。采集血样以评估与炎症和心血管健康相关的标志物。8周后,无论是休息时还是身体活动时,慢性疼痛均显著减轻(<0.01)。与每天服用2粒胶囊,分两次服用相比,每天服用3粒胶囊时改善更快。疼痛减轻导致睡眠质量改善(<0.1)、社交功能改善(<0.01)以及对他人支持的需求减少(<0.05)。研究开始时轻度升高的ABI在2周后恢复正常。血浆纤维蛋白原、血管性血友病因子和血清基质金属蛋白酶-9(MMP-9)在2周后有所降低(无统计学意义),而血清白细胞介素-1受体拮抗剂-a(IL-1ra)在2周后降低具有统计学意义(<0.05)。8周后疼痛减轻与MMP-9变化之间的相关性非常显著(<0.01),而对于每天服用3粒胶囊的组,疼痛减轻与IL-1ra变化之间的相关性在2周时达到显著水平(<0.04)。食用DSB有助于控制疼痛、增加日常活动中的舒适度并改善血管功能。这与对与炎症和血管健康相关的特定血液生物标志物的选择性作用有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d16/6526776/e62c2911d5b2/JPR-12-1497-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验